Financial Performance - Q3 2025 - StoneX Group Inc's operating revenues reached $1,024.3 million, a 12% increase compared to the previous year's fiscal Q3[9] - Net income increased by 2% to $63.4 million[9] - Diluted EPS decreased by 2% to $1.22[9] - Return on Equity (ROE) was 13.1%[9] Financial Performance - Trailing Twelve Months (TTM) - Operating revenues for the trailing twelve months reached $3,844.7 million, up 17%[9] - Net income for the trailing twelve months increased by 26% to $296.9 million[9] - Diluted EPS for the trailing twelve months increased by 22% to $5.87[9] - Return on Equity (ROE) was 16.6%[9] Segment Performance - Q3 2025 - Commercial segment net operating revenue was $221 million, a decrease of 24%[20] - Institutional segment net operating revenue was $200 million, an increase of 27%[20] Acquisition and Strategy - StoneX completed the acquisition of R.J O'Brien (RJO) on July 31st, 2025, which is expected to add approximately $6 billion in client float and 190 million in listed contract volumes[32]

Financial Performance & Growth Strategy - Brink's aims to grow organically by expanding ATM Managed Services (AMS) and Digital Retail Solutions (DRS) subscription-based recurring revenue[10] - The company is targeting mid-to-high teens organic growth in AMS/DRS over the mid-term[27, 28] - Brink's expects to expand profit margins by shifting revenue to AMS/DRS and driving cost productivity[10] - The company is focused on improving free cash flow conversion by expanding profit margins, reducing capital intensity, and shortening the cash cycle[10] - Brink's aims to maximize shareholder value through accretive capital allocation, targeting at least 50% of free cash flow to shareholder returns[11, 38] AMS/DRS Expansion & Market Opportunity - AMS/DRS expands Brink's addressable market by 2-3x, targeting retailers with over $5,000 cash per month and the remaining bank ATMs to be outsourced[17] - The company's network optimization with conversion to AMS/DRS results in reduced miles driven and process efficiency[22] - AMS/DRS is delivering growth and margin improvement, with AMS/DRS projected to be 24% of total revenue in 2025, up from 10% in 2020[24] 2025 Outlook - For the second quarter of 2025, Brink's projects total revenue between $1.25 billion and $1.3 billion, with organic growth of 3%-6%[47] - The adjusted EBITDA for Q2 2025 is expected to be between $205 million and $225 million, with a margin of approximately 16.9%[47] - The company anticipates earnings per share (EPS) for Q2 2025 to be in the range of $1.25 to $1.65[47]

Third Quarter Fiscal 2025 Earnings Lori Flees, CEO & President Kevin Willis, CFO Elizabeth Clevinger, Investor Relations 08.06.2025 SAFE HARBOR Forward-Looking Statements Certain statements herein, other than statements of historical fact, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may include, without limitation, statements about the proposed transaction to acquire Breeze Autocare, including its Oil Changers sto ...

Financial Performance - Non-GAAP operating earnings per share were $1.10, but adjusted for notable items, the figure rises to $1.41[8] - Assets Under Management/Administration (AUM/A) reached $1.1 trillion, an 8% increase year-over-year and 5% year-to-date[8] - The company returned $318 million to shareholders, resulting in a payout ratio of 74%, exceeding the target range of 60-70%[8] - The company is on track to generate $1.6-1.7 billion of organic cash in 2025, with approximately 50% originating from asset and wealth management[8] Strategic Initiatives - The Individual Life transaction closed on July 31st, generating approximately $2 billion in value and reducing mortality exposure by 75%[8] - The company expects $1 billion of incremental dividends to Holdings in the second half of 2025 from the Individual Life transaction[8] - Private Markets AUM increased by 20% year-over-year, reaching $77 billion[8,11] - The company ceded approximately $30 billion of annuity liabilities to its Bermuda entity[21] Segment Results - Retirement saw net inflows of $1.9 billion, supported by RILA and BlackRock LifePath Paycheck[8] - Wealth Management advisory net inflows amounted to $2.0 billion[8] - Asset Management experienced active net outflows of $4.8 billion, primarily in April[8]

Financial Performance - Q3 2025 sales decreased to $349.4 million from $427.8 million in Q3 2024 [17] - Q3 2025 diluted EPS increased to $0.49 from $0.06 in Q3 2024 [17] - Q3 2025 Non-GAAP Adjusted EPS decreased to $0.28 from $0.56 in Q3 2024 [17] - Q3 2025 Adjusted EBITDA decreased slightly to $44.6 million from $44.7 million in Q3 2024 [17] - Year-to-date sales decreased to $1,178.8 million from $1,349.0 million [17] - Year-to-date Non-GAAP Adjusted EPS decreased to $0.76 from $1.62 [17] - Year-to-date Adjusted EBITDA decreased to $136.0 million from $147.0 million [17] Segment Performance - Memorialization Q3 sales slightly increased to $203.7 million from $202.7 million [23] - Industrial Technologies Q3 sales decreased to $87.9 million from $91.7 million [28] - Brand Solutions Q3 sales decreased to $57.7 million from $133.4 million [33] Outlook - The company maintains adjusted EBITDA guidance of at least $190 million for fiscal year 2025, including the estimated 40% share of Propelis [14] - Customer quotes for energy storage solutions since early February 2025 have exceeded $150 million [14]

Financial Performance - Net loss attributable to common stockholders was $0.8 million, or $0.01 per diluted share[24], compared to a $3.1 million loss, or $0.05 per diluted share, in the prior year period[24] - Funds from operations (FFO) attributable to common stockholders and noncontrolling interest was $14.3 million, or $0.20 per share and unit[24], compared to $13.9 million, or $0.20 per share and unit, in the prior year period[24] - Adjusted funds from operations (AFFO) attributable to common stockholders and noncontrolling interest was $16.6 million, or $0.23 per share and unit[24], compared to $15.7 million, or $0.22 per share and unit, in the prior year period[24] - The company reaffirms its full year 2025 AFFO per share and unit guidance of $0.89 to $0.93[24] Portfolio and Investment Activities - Gross investment in real estate totaled $1.5 billion[9, 30] with 193 buildings across 35 states[9] - The company completed acquisitions of medical properties for an aggregate purchase price of $38.1 million with annualized base rent of $3.6 million in April 2025[24] - The company sold a medical facility in Chipley, Florida for gross proceeds of $1.4 million, resulting in a gain of $0.2 million[24] - Total annualized base rent (ABR) for the portfolio is $117.5 million[30] with a weighted average cap rate of 8.0%[9, 30] and leased occupancy of 94.5%[9, 30] Debt and Capitalization - The company's leverage was 47.2% as of June 30, 2025[24], and Net Debt / Annualized Adjusted EBITDAre was 6.8x for the second quarter of 2025[24] - As of August 4, 2025, the company's borrowing capacity under the credit facility was $177 million[24]

Financial Performance & Challenges - RYAM reported Q2 2025 revenue of $340 million, a decrease of $79 million compared to Q2 2024[59] - The company's Adjusted EBITDA for Q2 2025 was $28 million, down $40 million from Q2 2024[59] - RYAM faces an Adjusted Free Cash Flow deficit of $(52) million year-to-date[59] - The company's 2025 EBITDA guidance is projected to be in the range of $150 million to $160 million[14, 59] Segment Performance - Cellulose Specialties reported Q2 2025 sales of $208 million with an Adjusted EBITDA of $46 million, representing a 22% margin[60] - Cellulose Commodities experienced a negative Adjusted EBITDA of $(2) million on sales of $59 million, with a margin of (3%)[69] - Paperboard sales were $47 million with an Adjusted EBITDA of $5 million, resulting in an 11% margin[75] - High-Yield Pulp reported sales of $29 million and a negative Adjusted EBITDA of $(7) million, with a margin of (24%)[80] Strategic Initiatives & Outlook - RYAM aims to restore Temiscaming's profitability, targeting a $35 million improvement and positioning it for potential divestiture in 2026[22] - The company anticipates a 2027 run-rate EBITDA of $308 million for its core business, excluding the AGE project[26] - RYAM expects to generate approximately $30 million of cumulative incremental EBITDA by 2027 by capturing Cellulose Specialties market growth[35] - BioNova is expected to invest $110 million to generate ~$39 million in EBITDA, implying a build multiple of 28X[41]

Financial Performance - Adjusted Revenue for Q2 2025 was $754 million, a decrease of 2.6% year-over-year, or 2.7% in constant currency[5, 23] - Adjusted EBITDA for Q2 2025 was $37 million, resulting in an Adjusted EBITDA Margin of 4.9%[5, 23] - The company projects FY 2025 Adjusted Revenue to be between $3100 million and $3200 million, with an exit rate between $3200 million and $3300 million[40] - The company expects FY 2025 Adjusted EBITDA Margin to be between 50% and 55%, with an exit rate of approximately 8%[40] - Adjusted Free Cash Flow for Q2 2025 was negative $30 million[37, 39] - The company anticipates FY 2025 Adjusted Free Cash Flow to be between $0 million and $40 million, with an exit rate between $60 million and $80 million[41] Sales Metrics - New business signings ACV(Annual Contract Value) for Q2 2025 reached $150 million[5, 8] - New Business TCV(Total Contract Value) was $66 million in Q2 2025[8] - New Business ARR(Annual Recurring Revenue) was $66 million in Q2 2025[8, 18] - Net ARR Activity (TTM) reached $63 million[5, 10] Segment Performance - Commercial segment Adjusted Revenue was $365 million, a decrease of 5.9% year-over-year[28] - Government segment Adjusted Revenue was $238 million, a decrease of 2.9% year-over-year[28] - Transportation segment Adjusted Revenue was $151 million, an increase of 7.1% year-over-year[28] Balance Sheet - Total cash at the end of Q2 2025 was $294 million[34, 39] - Total debt was $602 million[34] - Net adjusted leverage ratio was 2.7x[34, 39] Portfolio Rationalization - The company has executed three divestitures in 2024, generating $778 million of net proceeds[43] - The company has identified additional rationalization opportunities representing up to $350 million of net proceeds[43]

Financial Performance Highlights - Owens Corning's Q2 2025 net sales from continuing operations reached $2747 million, a 10% increase compared to Q2 2024's $2497 million[13, 16] - Adjusted EBITDA for Q2 2025 was $703 million, up from $678 million in Q2 2024, while the adjusted EBITDA margin was 26% compared to 27%[13, 16] - Year-to-date 2025 net sales were $5277 million, a 17% increase from $4514 million in the same period of 2024[13, 16] - Year-to-date 2025 adjusted EBITDA reached $1268 million, compared to $1193 million in 2024, with adjusted EBITDA as a percentage of net sales at 24% versus 26%[13, 16] - Roofing business delivered Q2 2025 revenue of $1303 million, a 4% increase from $1252 million in the prior year, with an EBITDA of $457 million and a 35% EBITDA margin[20] - Insulation business delivered Q2 2025 revenue of $934 million, a 4% decrease from $974 million in the prior year, with an EBITDA of $225 million and a 24% EBITDA margin[23] - Doors business delivered Q2 2025 revenue of $554 million, with an EBITDA of $75 million and a 14% EBITDA margin[27] Balance Sheet and Capital Deployment - Free cash flow for Q2 2025 was $129 million[19] - $279 million of free cash flow was returned to shareholders through share repurchases and dividends in Q2 2025[19] - Capital additions totaled $198 million in Q2 2025[19] - The company maintained liquidity of $1700 million, including approximately $200 million in cash and $1500 million available on a bank debt facility[19] - Net debt-to-adjusted EBITDA ratio was 21x at the end of Q2 2025[19] Full-Year 2025 Outlook - General corporate EBITDA expenses are projected to be between $240 million and $260 million[33] - Interest expense is expected to be between $250 million and $260 million[33] - The full-year effective tax rate is projected to be between 24% and 26%[33] - Capital additions are estimated to be approximately $800 million[33] - Depreciation and amortization are expected to be approximately $650 million[33]

Financial Highlights - IGI's total assets reached approximately $700 million as of full year 2024[4] - The company's gross written premium was $2.1 billion as of June 30, 2025[4] - IGI reported a net income of $34.1 million for Q2 2025, a 4% increase over Q2 2024[20] - The company's net income for the first half of 2025 was $61.4 million, a 13.2% decrease compared to the first half of 2024[20] - IGI's book value per share increased by 4.8% from March 31, 2025, to $15.36[20] Underwriting Performance - IGI's combined ratio for Q2 2025 was 90.5%[20] - The combined ratio for the first half of 2025 was 92.4%[20] - Underwriting income for Q2 2025 was $35.0 million[20] - Underwriting income for the first half of 2025 was $63.0 million[20] Capital Management - IGI returned $33.5 million to shareholders in Q2 2025 through dividends and share repurchases[20] - The company returned $77.0 million to shareholders in the first half of 2025, including a $0.85 special dividend and share repurchases[20] - As of June 30, 2025, the Jabsheh family owned 35.8% of the company[9]